Molecular characterization of the human CRT-1 creatine transporter expressed in Xenopus oocytes

The protein sequence encoded by a creatine transporter cDNA cloned from a human heart library was identical to that cloned from a human kidney library (Nash et al., Receptors Channels 2, 165-174, 1994), except that at position 285 the former contained an Ala residue and the latter contained a Pro residue. Expression of this human heart cDNA clone in Xenopus laevis oocytes induced a Na+- and Cl--dependent creatine uptake activity that saturated with a K-n of similar to 20 mu M for creatine. The induced uptake was inhibited by beta-guanidinopropionic acid (IC50 similar to 44.4 mu M), 2-amino-1-imidazolidineacetic acid (cyclocreatine; IC50 similar to 369.8 mu M), gamma-guanidinobutyric acid (IC50 similar to 697.9 mu M), gamma-aminobutyric acid (IC50 similar to 6.47 mM), and amiloride (IC50 similar to 2.46 mM). The inhibitors beta-guanidinopropionic acid, cyclocreatine, and gamma-guanidinobutyric acid also inhibited the uptake activity of the Ala285 to Pro285 (A285P) mutant as effectively as that of the wild type. In contrast, guanidinoethane sulfonic acid, a potent inhibitor of taurine transport, inhibited the uptake activity of the A285P mutant approx. two times more effectively than that of the wild type. The protein kinase C activator phorbol 1-myristate 13-acetate (PMA), but not its inactive analog, 4 alpha-phorbol 12,13-didecanoate, inhibited the creatine uptake, and the inhibitory effect of PMA was both time and concentration dependent. The protein kinase A activator 8-bromo-cyclic AMP however, had no effect on the creatine uptake. The rate of uptake increased hyperbolically with the increasing concentration of the external Cl- (equilibrium constant KCl- similar to 5 mM) and sigmoidally with the increasing concentration of the external Na+ (equilibrium constant KNa+ similar to 56 mM). Further analyses of the Na+ and Cl- concentration dependence data suggested that at least two Na+ and one Cl- were required to transport one creatine molecule via the creatine transporter. (C) 1999 Academic Press.